In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 93 for your search:
Drug:  celecoxib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00869, ID99-368, N01CN85186, MDA-ID-99368, NCI-P00-0165, SC-NQ4-99-02-006, NCT00006124

2.

Phase: Phase III, Phase II
Type: Prevention
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: RUN 2008-4198, ABR nr.: NL23569.091.08, CMO: 2008/148, EudraCT: 2008-003696-43, NCT00808743

3.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 30 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02327, 98-008, NYH-CMC-0298-108, SC-IQ4-99-02-005, CDR0000067750, NCI-P00-0141, STRANG-98-008, BWH-NO1-CN-95015, N01CN95015, NCT00005094

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-40015, NCT00064181

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-40023, PETACC-5, NCT00085163

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SLCSG0501, NCT00300729

7.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EQ4-00-02-018, A3191107, NCT00141193

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000662707, CALGB-30801, NCT01041781

9.

Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0087

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: NCI, Other
Protocol IDs: RTOG-C-0128, CDR0000068849, NCT00023660

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0213, CDR0000069476, NCT00046839

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 3c-03-19, NCT00159484

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NP01/07/03, NCT00212108

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 02-0130-C, Ontario Cancer ResearchNetwork, NCT00188565

15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000490047, CHUV-CEPO-161-05, EU-20627, NCT00357617

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0405-2006, NCT00400374

17.

Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 0596-2004, NCT00314262

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: F020703003, Link No: 000276825, NCT00581971

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 02I6, NCT00057980

20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 01L2, PHARMACIA-NU-01L2, NCT00073866

21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00730, 2009-0804, N01CN35159, NCT01021215

22.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J9932, CDR0000067917, P30CA006973, JHOC-J9932, JHOC-99061108, NCI-P00-0145, NCT00005878

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-00078, NCI-G00-1869, NCT00006381

24.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 00-111, MSKCC-00111, NCI-G01-1930, NCT00014404

25.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 45
Sponsor: NCI, Other
Protocol IDs: CDR0000068727, P30CA016042, UCLA-0012067, NCI-G01-1966, NCT00020878
1     
New Search